Novo's week­ly in­sulin se­cures CHMP thumbs-up as FDA de­ci­sion looms

No­vo Nordisk is an­oth­er step clos­er to launch­ing its once-week­ly in­sulin icodec now that the Eu­ro­pean Med­i­cines Agency’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man Use …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.